Reference
Brandi G, et al. Can the tyrosine kinase inhibitors trigger metabolic encephalopathy in cirrhotic patients?. Liver International 33: 488-93, No. 3, Mar 2013. Available from: URL: http://dx.doi.org/10.1111/liv.12102 - Italy
Rights and permissions
About this article
Cite this article
Sorafenib. Reactions Weekly 1467, 34 (2013). https://doi.org/10.1007/s40278-013-5567-3
Published:
Issue Date:
DOI: https://doi.org/10.1007/s40278-013-5567-3